Search | Search by Center | Search by Source | Keywords in Title
Penna P, Cox E, Joseph T, Lehman L, Morrow T, Richter A, Sowers J, Tepper D. Roundtable discussion: Part II--Development of a pharmacoeconomic model in hypertension. Managed Care Interface. 2000 Oct 1; Suppl C:17-23.
Antihypertensive medications are targeted by most health plans as a major cost center. However, the efficacy of these medications, their side effects, and their resulting ability to prevent serious long-term complications must be factored into the value equation. To illustrate the possible economic effects of a single antihypertensive agent's inclusion on a health plan's drug formulary, an innovative pharmacoeconomic model was developed. In this portion of the roundtable, the design, results, and caveats of this model are discussed.